Daily Step Count Predicts Acute Exacerbations in a US Cohort with COPD

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Moy, Marilyn L ^a,b,c,d   Teylan, Merilee ^b   Weston, Nicole A ^b   Gagnon, David R ^e,f   Garshick, Eric ^a,b,c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f VA Cooperative Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LONG ACTING DRUG; MUSCARINIC RECEPTOR BLOCKING AGENT; OXYGEN; PREDNISONE; SHORT ACTING DRUG;

ACCELEROMETER; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE EXACERBATION; DRUG USE; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PREDICTION; PROSPECTIVE STUDY; SCORING SYSTEM; ST GEORGE RESPIRATORY QUESTIONNAIRE ACTIVITY SCORE; UNITED STATES; WALKING;

AGED; COHORT STUDIES; EXERCISE TEST; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; UNITED STATES; WALKING;

EID: 84875930122     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060400     Document Type: Article

References (51)

1. Mannino DM, Braman S, (2007) The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 4: 502-506.
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532-555.
3. Kocks JW, Asijee GM, Tsiligianni IG, Kerstjens HA, van der Molen T, (2011) Functional status measurement in COPD: a review of available methods and their feasibility in primary care. Prim Care Respir J 20: 269-725.
4. Puhan MA, Chandra D, Mosenifar Z, Ries A, Make B, et al. (2011) The minimal important difference of exercise tests in severe COPD. Eur Respir J 37: 784-790.
5. Moy ML, Matthess K, Stolzmann K, Reilly J, Garshick E, (2009) Free-living physical activity in COPD: assessment with accelerometer and activity checklist. J Rehabil Res Dev 46: 277-286.
6. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, et al. (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171: 972-977.
7. Watz H, Waschki B, Meyer T, Magnussen H, (2009) Physical activity in patients with COPD. Eur Respir J 33: 262-272.
8. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM, (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61: 772-778.
9. Garcia-Aymerich J, Farrero E, Félez MA, Izquierdo J, Marrades RM, et al. (2003) Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58: 100-105.
10. Waschki B, Spruit MA, Watz H, Albert PS, Shrikrishna D, et al. (2012) Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 106: 522-530.
11. Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, et al. (2006) Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med 173: 1326-1334.
12. Waschki B, Kirsten A, Holz O, Müller KC, Meyer T, et al. (2011) Physical activity is the strongest predictor of all-cause mortality in patients with COPD. A prospective cohort study. Chest 140: 331-342.
13. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, et al. (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363: 1128-1138.
14. Rodriguez-Roisin R, (2000) Toward a consensus definition for COPD exacerbation. Chest 117: 398S-401S.
15. Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA Jr, et al. (2011) Azithromycin for prevention of exacerbations of COPD. N Engl J Med 365: 689-698.
16. Connors AF Jr, Dawson NV, Thomas C, Harrell FE Jr, Desbiens N, et al. (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. Am J Respir Crit Care Med 154: 959-967.
17. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, et al. (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1418-1422.
18. Strassels SA, Smith DH, Sullivan SD, Mahajan PS, (2001) The costs of treating COPD in the United States. Chest 119: 344-352.
19. Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E, (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159: 158-164.
20. Garcia-Aymerich J, Monsó E, Marrades RM, Escarrabill J, Félez MA, et al. (2001) Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 164: 1002-1007.
21. Niewoehner DE, Lokhnygina Y, Rice K, Kuschner WG, Sharafkhaneh A, et al. (2007) Risk indexes for exacerbations and hospitalizations due to COPD. Chest 131: 20-28.
22. Jenkins CR, Celli B, Anderson JA, Ferguson GT, Jones PW, et al. (2012) Seasonality and determinants of moderate and severe COPD exacerbations in the TORCH study. Eur Respir J 39: 38-45.
23. Wells JM, Washko GR, Han MK, Abbas N, Nath H, et al. (2012) Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med 367: 913-921.
24. Seidel D, Cheung A, Suh ES, Raste Y, Atakhorrami M, et al. (2012) Physical inactivity and risk of hospitalization for chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 16: 1015-1019.
25. Benzo RP, Chang CCH, Farrell MH, Kaplan R, Ries A, et al. (2010) Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease. Respiration 80: 10-18.
26. Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, et al. (2012) Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc 13: 291-297.
27. Moy ML, Danilack VA, Weston NA, Garshick E, (2012) Daily step counts in a US cohort with COPD. Respir Med 106: 962-969.
28. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. (2005) Standardisation of spirometry. Eur Respir J 26: 319-338.
29. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test (2002) Am J Respir Crit Care Med 166: 111-117.
30. Mahler DA, Wells CK, (1988) Evaluation of clinical methods for rating dyspnea. Chest 93: 580-586.
31. Jones PW, Quirk FH, Baveystock CM, Littlejohns P, (1992) A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 145: 1321-1327.
32. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J, (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
33. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775-789.
34. Matthews CE, Hagstromer M, Pober DM, Bowles HR, (2012) Best practices for using physical activity monitors in population-based research. Med Sci Sports Exerc 44: S68-S76.
35. Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, et al. (2005) Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med 143: 317-326.
36. Aaron SD, Fergusson D, Marks GB, Suissa S, Vandemheen KL, et al. (2008) Counting, analysing and reporting exacerbations of COPD in randomised controlled trials. Thorax 63: 122-128.
37. Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, et al. (2012) Six minute walk test in COPD: Minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 187: 382-386.
38. Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, et al. (2010) Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 91: 221-225.
39. Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, et al. (2008) Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 32: 637-643.
40. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH, (1997) Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients. Am J Respir Crit Care Med 155: 1278-1282.
41. Hankinson JL, Odencrantz JR, Fedan KB, (1999) Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159: 179-187.
42. Jones PW, (2005) St. George's Respiratory Questionnaire: MCID. COPD 2: 75-79.
43. vanGestel AJR, Clarenbach CF, Stowhas AC, Rossi VA, Sievi NA, et al. (2012) Predicting daily physical activity in patients with chronic obstructive pulmonary disease. PLOS ONE 7: e48081.
44. Lee IM, Buchner DM, (2008) The importance of walking to public health. Med Sci Sports Exerc 40: S512-S518.
45. Moy ML, Weston NA, Wilson EJ, Hess ML, Richardson CR, (2012) A pilot study of an Internet walking program and pedometer in COPD. Respir Med 106: 1342-1350.
46. Faganello MM, Tanni SE, Sanchez FF, Pelegrino NR, Lucheta PA, et al. (2010) BODE index and GOLD staging as predictors of 1-year exacerbation risk in chronic obstructive pulmonary disease. Am J Med Sci 339: 10-14.
47. Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, et al. (2011) Chronic obstructive pulmonary disease exacerbations in the COPD Gene study: associated radiologic phenotypes. Radiology 261: 274-282.
48. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, et al. (2008) A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359: 1543-1554.
49. Walker PP, Burnett A, Flavahan PW, Calverley PMA, (2008) Lower limb activity and its determinants in COPD. Thorax 63: 683-689.
50. Depew ZS, Novotny PJ, Benzo RP, (2012) How many steps are enough to avoid severe physical inactivity in patients with chronic obstructive pulmonary disease? Respirology 17: 1026-1027.
51. Agustí A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, et al. (2012) Persistent systematic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype. PLOS ONE 7: e37483.